Tags

Type your tag names separated by a space and hit enter

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
Brain. 2006 Mar; 129(Pt 3):729-35.B

Abstract

To determine which clinical feature(s) [among visual hallucinations (VH), extrapyramidal signs (EPS) and visuospatial impairment] in the earliest stages of disease best predicted a diagnosis of dementia with Lewy bodies (DLB) at autopsy, first-visit data of 23 pathologically proven DLB and 94 Alzheimer's disease cases were compared. There were no group differences with regard to age, gender, education or global severity of dementia at presentation (mean Mini-Mental State Examination: 24.0 versus 25.0, mean Dementia Rating Scale: 123.6 versus 125.7). DLB patients at initial presentation displayed an increased frequency of VH (P = 0.001), but not EPS (P = 0.3), compared to Alzheimer's disease patients. However, only a minority of DLB cases had either VH (22%), EPS (26%) or both (13%). In contrast, although not a core feature, visuospatial/constructional impairment was observed in most of the DLB cases (74%). Among clinical variables, presence/recent history of VH was the most specific to DLB (99%), and visuospatial impairment was the most sensitive (74%). As a result, VH at presentation were the best positive predictor of DLB at autopsy (positive predictive value: 83% versus 32% or less for all other variables), while lack of visuospatial impairment was the best negative predictor (negative predictive value: 90%). We conclude that the best model for differentiating DLB from Alzheimer's disease in the earliest stages of disease includes VH and visuospatial/constructional dysfunction, but not spontaneous EPS, as predictors. This suggests that clinical history plus a brief assessment of visuospatial function may be of the greatest value in correctly identifying DLB early during the course of disease.

Authors+Show Affiliations

Dipartimento di Scienze Neurologiche, Ospedale Niguarda Ca' Granda, Milano, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

16401618

Citation

Tiraboschi, Pietro, et al. "What Best Differentiates Lewy Body From Alzheimer's Disease in Early-stage Dementia?" Brain : a Journal of Neurology, vol. 129, no. Pt 3, 2006, pp. 729-35.
Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain. 2006;129(Pt 3):729-35.
Tiraboschi, P., Salmon, D. P., Hansen, L. A., Hofstetter, R. C., Thal, L. J., & Corey-Bloom, J. (2006). What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a Journal of Neurology, 129(Pt 3), 729-35.
Tiraboschi P, et al. What Best Differentiates Lewy Body From Alzheimer's Disease in Early-stage Dementia. Brain. 2006;129(Pt 3):729-35. PubMed PMID: 16401618.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? AU - Tiraboschi,Pietro, AU - Salmon,David P, AU - Hansen,Lawrence A, AU - Hofstetter,Richard C, AU - Thal,Leon J, AU - Corey-Bloom,Jody, Y1 - 2006/01/09/ PY - 2006/1/13/pubmed PY - 2006/3/16/medline PY - 2006/1/13/entrez SP - 729 EP - 35 JF - Brain : a journal of neurology JO - Brain VL - 129 IS - Pt 3 N2 - To determine which clinical feature(s) [among visual hallucinations (VH), extrapyramidal signs (EPS) and visuospatial impairment] in the earliest stages of disease best predicted a diagnosis of dementia with Lewy bodies (DLB) at autopsy, first-visit data of 23 pathologically proven DLB and 94 Alzheimer's disease cases were compared. There were no group differences with regard to age, gender, education or global severity of dementia at presentation (mean Mini-Mental State Examination: 24.0 versus 25.0, mean Dementia Rating Scale: 123.6 versus 125.7). DLB patients at initial presentation displayed an increased frequency of VH (P = 0.001), but not EPS (P = 0.3), compared to Alzheimer's disease patients. However, only a minority of DLB cases had either VH (22%), EPS (26%) or both (13%). In contrast, although not a core feature, visuospatial/constructional impairment was observed in most of the DLB cases (74%). Among clinical variables, presence/recent history of VH was the most specific to DLB (99%), and visuospatial impairment was the most sensitive (74%). As a result, VH at presentation were the best positive predictor of DLB at autopsy (positive predictive value: 83% versus 32% or less for all other variables), while lack of visuospatial impairment was the best negative predictor (negative predictive value: 90%). We conclude that the best model for differentiating DLB from Alzheimer's disease in the earliest stages of disease includes VH and visuospatial/constructional dysfunction, but not spontaneous EPS, as predictors. This suggests that clinical history plus a brief assessment of visuospatial function may be of the greatest value in correctly identifying DLB early during the course of disease. SN - 1460-2156 UR - https://www.unboundmedicine.com/medline/citation/16401618/What_best_differentiates_Lewy_body_from_Alzheimer's_disease_in_early_stage_dementia L2 - https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/awh725 DB - PRIME DP - Unbound Medicine ER -